CB20137-2 - 0x0000000000002FA3

Study Number: CB20137
Group Number: 2
Study Requirement: Cystic Fibrosis
Stipend: up to £ 2,350

Study Criteria:

  • Age: 18 - 55
  • BMI: 18 - 32
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD).
  • Route of Administration: Inhalation
  • Blood Draws: 56

Study Schedule:

  • Schedule Type: Return Only
  • Study Length: 21 Returns & 46 Phone Calls

Screening Dates:

Event Day Event Date Site
No search results

Doctor Exam Dates:

Event Day Event Date Site
No search results

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
No search results